282 related articles for article (PubMed ID: 6405619)
1. Variation of serum prolactin-releasing activity in women with the galactorrhea-amenorrhea syndrome after bromocriptine treatment.
Takahashi K; Minato K; Ikeno N; Watanabe M; Endo H; Yamamoto H
Am J Obstet Gynecol; 1983 May; 146(1):74-9. PubMed ID: 6405619
[TBL] [Abstract][Full Text] [Related]
2. Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.
March CM; Kletzky OA; Davajan V
Fertil Steril; 1977 May; 28(5):521-5. PubMed ID: 404198
[TBL] [Abstract][Full Text] [Related]
3. [Prolactin releasing activity in serum of pregnant women and patients with galactorrhea-amenorrhea syndrome].
Takahashi K; Ikeno N; Minato K; Fukaya T; Momono K; Hoshiai H; Furuhashi N
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Sep; 34(9):1479-86. PubMed ID: 7130769
[TBL] [Abstract][Full Text] [Related]
4. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
Mroueh AM; Siler-Khodr TM
Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
[TBL] [Abstract][Full Text] [Related]
5. Ineffectiveness of pyridoxine (B6) to alter secretion of growth hormone and prolactin and absence of therapeutic effects on galactorrhea-amenorrhea syndromes.
Tolis G; Laliberté R; Guyda H; Naftolin F
J Clin Endocrinol Metab; 1977 Jun; 44(6):1197-9. PubMed ID: 559690
[TBL] [Abstract][Full Text] [Related]
6. 2alpha-bromoergocryptine in the management of the amenorrhea-galactorrhea syndrome. Clinical and endocrinological evaluation of response to treatment.
Barreca P; Giannola C; Palisi F
Acta Eur Fertil; 1978 Mar; 9(1):21-9. PubMed ID: 567920
[No Abstract] [Full Text] [Related]
7. [Bromocriptine treatment of amenorrhea with hyperprolactinemia and galactorrhea].
Hiroi M; Kawakoshi S; Kaneko N
Horumon To Rinsho; 1983 Jan; 31(1):95-9. PubMed ID: 6682727
[No Abstract] [Full Text] [Related]
8. [Serum prolactin level and bromoergocriptine therapy in galactorrhea and oligo- or amenorrhea].
Baron J; Warenik-Szymankiewicz A; Chwalisz K
Ginekol Pol; 1981 Jun; 52(6):517-20. PubMed ID: 7197249
[No Abstract] [Full Text] [Related]
9. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
Farrari C; Telloli P; Rampini P; Caldara R
Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
[TBL] [Abstract][Full Text] [Related]
10. Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.
Mroueh AM; Siler-Khodr TM
J Clin Endocrinol Metab; 1976 Dec; 43(6):1398-401. PubMed ID: 1036743
[TBL] [Abstract][Full Text] [Related]
11. Plasma prolactin-releasing factor-like activity in the amenorrhea-galactorrhea syndrome.
Garthwaite TL; Hagen TC
J Clin Endocrinol Metab; 1978 Oct; 47(4):885-8. PubMed ID: 122415
[TBL] [Abstract][Full Text] [Related]
12. Ovulatory response to clomiphene citrate during bromocriptine-failed ovulation in amenorrhea-galactorrhea and hyperprolactinemia.
Turksoy RN; Biller BJ; Farber M; Cetrulo C; Mitchell GW
Fertil Steril; 1982 Mar; 37(3):441-4. PubMed ID: 6800855
[No Abstract] [Full Text] [Related]
13. Restoration of ovarian function by low nocturnal single daily doses of bromocriptine in patients with the galactorrhea-amenorrhea syndrome.
de Bernal M; de Villamizar M
Fertil Steril; 1982 Mar; 37(3):392-6. PubMed ID: 6800849
[TBL] [Abstract][Full Text] [Related]
14. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
Seki K; Seki M; Okumura T
Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
[TBL] [Abstract][Full Text] [Related]
15. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
Dickey RP; Stone SC
Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
[TBL] [Abstract][Full Text] [Related]
16. Effect of triiodothyronine treatment on prolactin secretion in patients with amenorrhea-galactorrhea.
Aono T; Shioji T; Miyai K; Onishi T; Kurachi K
J Clin Endocrinol Metab; 1977 Jan; 44(1):8-14. PubMed ID: 401825
[TBL] [Abstract][Full Text] [Related]
17. Predicted ovulatory response to 2-brom-alpha-ergocryptine (CB-154) in amenorrhea-galactorrhea syndromes.
Shewchuk AB; Corenblum B; Pairaudeau N; Ezrin C; Adamson GD
Am J Obstet Gynecol; 1980 Mar; 136(5):652-8. PubMed ID: 7188835
[TBL] [Abstract][Full Text] [Related]
18. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
Lamberts SW; Seldenrath HJ; Kwa HG; Birkenhäger JC
J Clin Endocrinol Metab; 1977 Jan; 44(1):180-4. PubMed ID: 576229
[TBL] [Abstract][Full Text] [Related]
19. Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea.
Aono T; Miyake A; Yasuda TS; Koike K; Kurachi K
Acta Endocrinol (Copenh); 1979 Aug; 91(4):591-600. PubMed ID: 227202
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy following thyroid hormone treatment in a patient with amenorrhea-galactorrhea due to primary hypothyroidism.
Aono T; Shioji T; Onishi T; Kurachi H; Miyai K
Fertil Steril; 1977 Aug; 28(8):878-80. PubMed ID: 885277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
